File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/cbic.201000604
- Scopus: eid_2-s2.0-79952010449
- PMID: 21271629
- WOS: WOS:000288080700017
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation
Title | Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||||||
Keywords | Alpha-synuclein Amyloid beta-peptides Baicalein Neurological agents Oligomerization | ||||||||||||
Issue Date | 2011 | ||||||||||||
Publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.chembiochem.com | ||||||||||||
Citation | Chembiochem, 2011, v. 12 n. 4, p. 615-624 How to Cite? | ||||||||||||
Abstract | Abnormal protein aggregation in the brain is linked to the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Recent studies revealed that the oligomeric form of aggregates is most likely the toxic species, and thus could be a good therapeutic target. To screen for potent inhibitors that can inhibit both oligomerisation and fibrillation of α-synuclein (α-syn), we systematically compared the antioligomeric and antifibrillar activities of eight compounds that were extracted from Chinese herbal medicines through three platforms that can monitor the formation of α-syn fibrils and oligomers in cell-free or cellular systems. Our results revealed that baicalein, a flavonoid extracted from the Chinese herbal medicine Scutellaria baicalensis Georgi ("huang qin" in Chinese), is a potent inhibitor of α-syn oligomerisation both in cell-free and cellular systems, and is also an effective inhibitor of α-syn fibrillation in cell-free systems. We further tested the protective effect of baicalein against α-syn-oligomer-induced toxicity in neuronal cells. Our data showed that baicalein inhibited the formation of α-syn oligomers in SH-SY5Y and Hela cells, and protected SH-SY5Y cells from α-syn-oligomer-induced toxicity. We also explored the effect of baicalein on amyloid-β peptide (Aβ) aggregation and toxicity. We found that baicalein can also inhibit Aβ fibrillation and oligomerisation, disaggregate pre-formed Aβ amyloid fibrils and prevent Aβ fibril-induced toxicity in PC12 cells. Our study indicates that baicalein is a good inhibitor of amyloid protein aggregation and toxicity. Given the role of these processes in neurodegenerative diseases such as AD and PD, our results suggest that baicalein has potential as a therapeutic agent for the treatment of these devastating disorders. Arrested aggregation: Baicalein, a flavonoid from the Chinese herbal medicine Scutellaria baicalensis Georgi, is a potent inhibitor of α-syn oligomerisation both in cell-free and cellular systems, and is also a effective inhibitor of α-syn fibrillation in cell-free systems. It inhibits the formation of α-syn oligomers in SH-SY5Y and Hela cells, and protects SH-SY5Y cells from α-syn-oligomer-induced toxicity. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | ||||||||||||
Persistent Identifier | http://hdl.handle.net/10722/147627 | ||||||||||||
ISSN | 2023 Impact Factor: 2.6 2023 SCImago Journal Rankings: 0.809 | ||||||||||||
ISI Accession Number ID |
Funding Information: GNS and SGC plasmids were generous gifts from Dr. Pamela J. McLean, Harvard University, USA. NU1 antibody was donated by Dr. William L. Klein, Northwestern University, USA. 10G4 antibody was donated by Drs. Fusheng Yang and Greg Cole, University of California, USA. The study was supported by research grant FRG-II/09-10/051 from Hong Kong Baptist University, and also it was partly supported by grant EYS/07-08/01 from Eu Yan Sang (Hong Kong) Limited. We especially thank Pui-Chun Lam, Wai-Sheung Chan and the Lions Club of South Kowloon, H.K. for their further financial support of this study. The laboratory of O.M.E. is supported by Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences (Dubai, UAE; Grant MRG-23/2005-2006), and UAE University (Al Ain, UAE; Interdisciplinary Research Project 01-03-8-12/08). We would also like to thank Dr. Martha Dahlen for her critical review and revision. | ||||||||||||
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lu, JH | en_US |
dc.contributor.author | Ardah, MT | en_US |
dc.contributor.author | Durairajan, SSK | en_US |
dc.contributor.author | Liu, LF | en_US |
dc.contributor.author | Xie, LX | en_US |
dc.contributor.author | Fong, WFD | en_US |
dc.contributor.author | Hasan, MY | en_US |
dc.contributor.author | Huang, JD | en_US |
dc.contributor.author | ElAgnaf, OMA | en_US |
dc.contributor.author | Li, M | en_US |
dc.date.accessioned | 2012-05-29T06:05:04Z | - |
dc.date.available | 2012-05-29T06:05:04Z | - |
dc.date.issued | 2011 | en_US |
dc.identifier.citation | Chembiochem, 2011, v. 12 n. 4, p. 615-624 | en_US |
dc.identifier.issn | 1439-4227 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/147627 | - |
dc.description.abstract | Abnormal protein aggregation in the brain is linked to the pathogenesis of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Recent studies revealed that the oligomeric form of aggregates is most likely the toxic species, and thus could be a good therapeutic target. To screen for potent inhibitors that can inhibit both oligomerisation and fibrillation of α-synuclein (α-syn), we systematically compared the antioligomeric and antifibrillar activities of eight compounds that were extracted from Chinese herbal medicines through three platforms that can monitor the formation of α-syn fibrils and oligomers in cell-free or cellular systems. Our results revealed that baicalein, a flavonoid extracted from the Chinese herbal medicine Scutellaria baicalensis Georgi ("huang qin" in Chinese), is a potent inhibitor of α-syn oligomerisation both in cell-free and cellular systems, and is also an effective inhibitor of α-syn fibrillation in cell-free systems. We further tested the protective effect of baicalein against α-syn-oligomer-induced toxicity in neuronal cells. Our data showed that baicalein inhibited the formation of α-syn oligomers in SH-SY5Y and Hela cells, and protected SH-SY5Y cells from α-syn-oligomer-induced toxicity. We also explored the effect of baicalein on amyloid-β peptide (Aβ) aggregation and toxicity. We found that baicalein can also inhibit Aβ fibrillation and oligomerisation, disaggregate pre-formed Aβ amyloid fibrils and prevent Aβ fibril-induced toxicity in PC12 cells. Our study indicates that baicalein is a good inhibitor of amyloid protein aggregation and toxicity. Given the role of these processes in neurodegenerative diseases such as AD and PD, our results suggest that baicalein has potential as a therapeutic agent for the treatment of these devastating disorders. Arrested aggregation: Baicalein, a flavonoid from the Chinese herbal medicine Scutellaria baicalensis Georgi, is a potent inhibitor of α-syn oligomerisation both in cell-free and cellular systems, and is also a effective inhibitor of α-syn fibrillation in cell-free systems. It inhibits the formation of α-syn oligomers in SH-SY5Y and Hela cells, and protects SH-SY5Y cells from α-syn-oligomer-induced toxicity. © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. | en_US |
dc.language | eng | en_US |
dc.publisher | Wiley - V C H Verlag GmbH & Co KGaA. The Journal's web site is located at http://www.chembiochem.com | en_US |
dc.relation.ispartof | ChemBioChem | en_US |
dc.subject | Alpha-synuclein | - |
dc.subject | Amyloid beta-peptides | - |
dc.subject | Baicalein | - |
dc.subject | Neurological agents | - |
dc.subject | Oligomerization | - |
dc.subject.mesh | Amyloid - Biosynthesis | en_US |
dc.subject.mesh | Cell Survival - Drug Effects | en_US |
dc.subject.mesh | Cells, Cultured | en_US |
dc.subject.mesh | Drugs, Chinese Herbal - Chemistry - Pharmacology | en_US |
dc.subject.mesh | Enzyme Inhibitors - Chemistry - Pharmacology | en_US |
dc.subject.mesh | Flavanones - Chemistry - Pharmacology | en_US |
dc.subject.mesh | Hela Cells | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Molecular Structure | en_US |
dc.subject.mesh | Alpha-Synuclein - Antagonists & Inhibitors - Chemistry | en_US |
dc.title | Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation | en_US |
dc.type | Article | en_US |
dc.identifier.email | Huang, JD:jdhuang@hkucc.hku.hk | en_US |
dc.identifier.authority | Huang, JD=rp00451 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1002/cbic.201000604 | en_US |
dc.identifier.pmid | 21271629 | - |
dc.identifier.scopus | eid_2-s2.0-79952010449 | en_US |
dc.identifier.hkuros | 192259 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-79952010449&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 12 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 615 | en_US |
dc.identifier.epage | 624 | en_US |
dc.identifier.isi | WOS:000288080700017 | - |
dc.publisher.place | Germany | en_US |
dc.identifier.scopusauthorid | Lu, JH=16175647100 | en_US |
dc.identifier.scopusauthorid | Ardah, MT=36668287000 | en_US |
dc.identifier.scopusauthorid | Durairajan, SSK=23469201000 | en_US |
dc.identifier.scopusauthorid | Liu, LF=40561366800 | en_US |
dc.identifier.scopusauthorid | Xie, LX=23483050700 | en_US |
dc.identifier.scopusauthorid | Fong, WFD=36833162500 | en_US |
dc.identifier.scopusauthorid | Hasan, MY=55057475100 | en_US |
dc.identifier.scopusauthorid | Huang, JD=8108660600 | en_US |
dc.identifier.scopusauthorid | ElAgnaf, OMA=7003671192 | en_US |
dc.identifier.scopusauthorid | Li, M=36071647500 | en_US |
dc.identifier.issnl | 1439-4227 | - |